Literature DB >> 25301993

Magnetic nanoparticle hyperthermia: Predictive model for temperature distribution.

Robert V Stigliano1, Fridon Shubitidze1, Alicia A Petryk1, Jennifer A Tate1, P Jack Hoopes2.   

Abstract

Magnetic nanoparticle (mNP) hyperthermia is a promising adjuvant cancer therapy. mNP's are delivered intravenously or directly into a tumor, and excited by applying an alternating magnetic field (AMF). The mNP's are, in many cases, sequestered by cells and packed into endosomes. The proximity of the mNP's has a strong influence on their ability to heat due to inter-particle magnetic interaction effects. This is an important point to take into account when modeling the mNP's. Generally, more mNP heating can be achieved using higher magnetic field strengths. The factor which limits the maximum field strength applied to clinically relevant volumes of tissue is the heating caused by eddy currents, which are induced in the noncancerous tissue. A coupled electromagnetic and thermal model has been developed to predict dynamic thermal distributions during AMF treatment. The EM model is based on the method of auxiliary sources and the thermal modeling is based on the Pennes bioheat equation. The results of our phantom study are used to validate the model which takes into account nanoparticle heating, interaction effects, particle spatial distribution, particle size distribution, EM field distribution, and eddy current generation in a controlled environment. Preliminary in vivo data for model validation are also presented. Once fully developed and validated, the model will have applications in experimental design, AMF coil design, and treatment planning.

Entities:  

Keywords:  cancer therapy; eddy currents; hyperthermia; magnetic nanoparticle; method of auxiliary sources; phantom; predictive model; thermal imaging; treatment planning

Year:  2013        PMID: 25301993      PMCID: PMC4187246          DOI: 10.1117/12.2007673

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  18 in total

Review 1.  Intensity-modulated radiotherapy: current status and issues of interest.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-15       Impact factor: 7.038

2.  Radiofrequency ablation: importance of background tissue electrical conductivity--an agar phantom and computer modeling study.

Authors:  Stephanie A Solazzo; Zhengjun Liu; S Melvyn Lobo; Muneeb Ahmed; Andrew U Hines-Peralta; Robert E Lenkinski; S Nahum Goldberg
Journal:  Radiology       Date:  2005-08       Impact factor: 11.105

3.  Iron Oxide Hyperthermia And Radiation Cancer Treatment.

Authors:  Sm Cassim; Aj Giustini; Aa Petryk; Ra Strawbridge; Pj Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-23

4.  Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments.

Authors:  Fabio Sonvico; Stéphane Mornet; Sébastien Vasseur; Catherine Dubernet; Danielle Jaillard; Jeril Degrouard; Johan Hoebeke; Etienne Duguet; Paolo Colombo; Patrick Couvreur
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

5.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Authors:  M J Zelefsky; Z Fuks; M Hunt; H J Lee; D Lombardi; C C Ling; V E Reuter; E S Venkatraman; S A Leibel
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

6.  The response of human and rodent cells to hyperthermia.

Authors:  L Roizin-Towle; J P Pirro
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-04       Impact factor: 7.038

7.  Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathway.

Authors:  Konjeti R Sekhar; Vijayakumar N Sonar; Venkatraj Muthusamy; Soumya Sasi; Andrei Laszlo; Jamil Sawani; Nobuo Horikoshi; Ryuji Higashikubo; Robert G Bristow; Michael J Borrelli; Peter A Crooks; James R Lepock; Joseph L Roti Roti; Michael L Freeman
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

8.  Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.

Authors:  Hoon Choi; Seok Rye Choi; Rong Zhou; Hank F Kung; I-Wei Chen
Journal:  Acad Radiol       Date:  2004-09       Impact factor: 3.173

Review 9.  Hyperthermia: a potent enhancer of radiotherapy.

Authors:  M R Horsman; J Overgaard
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-05-10       Impact factor: 4.126

10.  MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT.

Authors:  Andrew J Giustini; Alicia A Petryk; Shiraz M Cassim; Jennifer A Tate; Ian Baker; P Jack Hoopes
Journal:  Nano Life       Date:  2010-03
View more
  5 in total

1.  Mitigation of eddy current heating during magnetic nanoparticle hyperthermia therapy.

Authors:  Robert V Stigliano; Fridon Shubitidze; James D Petryk; Levan Shoshiashvili; Alicia A Petryk; P Jack Hoopes
Journal:  Int J Hyperthermia       Date:  2016-07-20       Impact factor: 3.914

2.  Magnetic nanoparticles with high specific absorption rate of electromagnetic energy at low field strength for hyperthermia therapy.

Authors:  Fridon Shubitidze; Katsiaryna Kekalo; Robert Stigliano; Ian Baker
Journal:  J Appl Phys       Date:  2015-03-03       Impact factor: 2.546

Review 3.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

Review 4.  Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.

Authors:  Keon Mahmoudi; Alexandros Bouras; Dominique Bozec; Robert Ivkov; Constantinos Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2018-02-06       Impact factor: 3.914

Review 5.  Computational nanomedicine: modeling of nanoparticle-mediated hyperthermal cancer therapy.

Authors:  Chanchala D Kaddi; John H Phan; May D Wang
Journal:  Nanomedicine (Lond)       Date:  2013-08       Impact factor: 5.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.